- Home
- ZVRA vs GAIN Comparison
ZVRA vs GAIN Comparison
Compare ZVRA & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZVRA | GAIN |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 551.1M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ZVRA | GAIN |
|---|---|---|
| Price | $8.16 | $13.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $21.71 | $14.50 |
| AVG Volume (30 Days) | ★ 1.2M | 124.3K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 15.76% |
| EPS Growth | N/A | ★ 135.24 |
| EPS | 0.54 | ★ 2.49 |
| Revenue | $84,388,000.00 | ★ $97,742,000.00 |
| Revenue This Year | $333.25 | $7.46 |
| Revenue Next Year | $43.70 | $5.05 |
| P/E Ratio | $15.50 | ★ $5.60 |
| Revenue Growth | ★ 244.60 | 6.86 |
| 52 Week Low | $6.19 | $11.42 |
| 52 Week High | $13.16 | $15.34 |
Technical Indicators
Market Signals| Indicator | ZVRA | GAIN |
|---|---|---|
| Relative Strength Index (RSI) | 36.63 | 51.00 |
| Support Level | $8.12 | $13.90 |
| Resistance Level | $9.03 | $14.04 |
| Average True Range (ATR) | 0.35 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 3.63 | 44.44 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.